Associations of IL-10 Gene Polymorphisms with Acute Myeloid Leukemia in Hunan, China |
Yao, Chen-Jiao
(Department of Hematology, The Third Xiangya Hospital of Central South University)
Du, Wei (Department of Hematology, The Third Xiangya Hospital of Central South University) Chen, Hai-Bing (Department of Hematology, The Third Xiangya Hospital of Central South University) Xiao, Sheng (Department of Hematology, The Third Xiangya Hospital of Central South University) Wang, Cheng-Hong (Department of Hematology, The Third Xiangya Hospital of Central South University) Fan, Zi-Li (Department of Hematology, The Third Xiangya Hospital of Central South University) |
1 | Chen KF, Li B, Wei YG, et al (2010). Interleukin-10 -819 promoter polymorphism associated with gastric cancer among Asians. J Int Med Res, 38, 1-8. DOI |
2 | Cunningham LM, Chapman C, Dunstan R, et al (2003). Polymorphisms in the interleukin 10 gene promoter are associated with susceptibility to aggressive non-Hodgkin's lymphoma. Leuk Lymphoma, 44, 251-5. DOI |
3 | Eskdale J, Kube D, Tesch H, et al (1997). Mapping of the human IL10 gene and further characterization of the 5' flanking sequence. Immunogenetics, 46, 120-8. DOI ScienceOn |
4 | Gibson AW, Edberg JC, Wu J, et al (2001). Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol, 166, 3915-22. DOI |
5 | Hsieh CL, Chen DS, Hwang LH(2000). Tumor-induced immunosuppression: a barrier to immunotherapy of large tumors by cytokine-secreting tumor vaccine. Hum Gene Ther, 11, 681-92. DOI ScienceOn |
6 | Lan Q, Zheng T, Rothman N, et al (2006). Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood, 107, 4101-8. DOI ScienceOn |
7 | Lan Y, Tan J, Wu J, et al (2007). The association of the IL-10 promoter polymorphisms and the systemic lupus erythematosus of Zhuang People in Guangxi. Chinese J Depart Dermatol, 40, 555-7. |
8 | Lin WP, Lin JH, Chen XW, et al (2011). Interleukin-10 promoter polymorphisms associated with susceptibility to lumbar disc degeneration in a Chinese cohort. Genet Mol Res, 10, 1719-27. DOI |
9 | Li QY, Guo ZZ, Liang J, et al (2012). Interleukin-10 genotype correlated to deficiency syndrome in hepatitis B cirrhosis. Evid Based Complement Alternat Med, 2012, 298925. |
10 | Mok CC, Lanchbury JS, Chan DW, et al (1998). Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum, 41, 1090-5. DOI ScienceOn |
11 | Villalta SA, Rinaldi C, Deng B, et al (2011). Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype. Hum Mol Genet, 20, 790-805. DOI ScienceOn |
12 |
Yang Y, Zhang WG, Qiao YC, et al (2002). The quantitate method of serum IFN- |
13 | Zhang ZN, Shen T (2008). Standard of diagnosis and treatment of blood diseases. 3rd ed., China, 139-47. |
14 | Zhou Y, Li N, Zhuang W, et al (2008). Interleukin-10 -1082 promoter polymorphism associated with gastric cancer among Asians. Eur J Cancer, 44, 2648-54. DOI ScienceOn |
15 | Zhuang W, Wu XT, Zhou Y, et al (2010). Interleukin10 -592 promoter polymorphism associated with gastric cancer among Asians: a meta-analysis of epidemiologic studies. Dig Dis Sci, 55, 1525-32. DOI |
![]() |